InvestorsHub Logo
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

Re: None

Sunday, 10/29/2017 3:25:11 PM

Sunday, October 29, 2017 3:25:11 PM

Post# of 59
Poster from today's presentation at AACR-EORTC available here...

http://www.mersana.com/our-technology#scientific_publications

Essentially 83% ORR in NaPi2b+ ovarian cancer (n mice).

60% (NapI2b +) of ovarian cancer is ~$4B market opportunity (all lines).


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRSN News